Although studies in patients clearly indicate impaired insulin signaling in both AD and stroke, there has been little investigation of insulin or IGF signaling as a consequence of striatal ischemia and Aβ toxicity, as well as the etiologic link between ischemia and AD. The gene discussed is INS; the disease is stroke disorder.